Skip to main content
Top
Published in: Drugs & Aging 8/2012

01-08-2012 | Short Communication

Effects of a Drug Minimization Guide on Prescribing Intentions in Elderly Persons with Polypharmacy

Authors: Dr Ian A. Scott, MBBS, FRACP, MHA, MEd, Leonard C. Gray, Jennifer H. Martin, Charles A. Mitchell

Published in: Drugs & Aging | Issue 8/2012

Login to get access

Abstract

Background

While frameworks exist to assist clinicians in prescribing appropriately in older patients at risk of adverse drug reactions, their impact on prescribing is uncertain.

Objective

The aim of the study was to determine the effects of a ten-step drug minimization guide on clinician prescribing intentions involving a hypothetical older patient receiving multiple drugs.

Methods

A total of 61 hospital clinicians were presented with clinical information about a hypothetical case: an 81-year-old female with 12 chronic diseases, receiving 19 different medications. On a standardized, anonymous form, each participant indicated, as a pre-test, which drugs they felt strongly inclined to discontinue or continue, and which drugs they were uncertain about. The ten-step guide was then presented and applied to the case, and participants repeated the drug selection process.

Results

Sixty evaluable forms were analysed from 19 consultant physicians, 17 medical registrars, 7 interns/residents and 17 pharmacists. Among the entire cohort, the mean (±SD) number of drugs selected for discontinuation increased from 6.0 (±2.7) pre-test to 9.6 (±3.2) post-test (p < 0.001), with the greatest increases seen among consultant physicians (6.6 [±2.3] to 11.5 [±2.9], p < 0.001) and clinical pharmacists (5.3 [±2.6] to 8.9 [±2.2], p <0.001). The number of drugs associated with uncertainty decreased from 3.7 (±2.9) pretest to 1.8 (±2.3) post-test (p < 0.001) for the whole cohort, with the greatest decreases seen among consultant physicians (4.8 [±2.6] to 1.8 [±2.5], p < 0.001) and clinical pharmacists (4.5 [±3.3] to 1.9 [±2.0], p = 0.003).

Conclusion

This self-report study involving a hypothetical case provides evidence that a drug minimization guide may reduce inappropriate prescribing and uncertainty around drug indications.
Literature
1.
go back to reference Gallagher PF, Barry PJ, Ryan C, et al. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers’ Criteria. Age Ageing 2008; 37: 96–101.PubMedCrossRef Gallagher PF, Barry PJ, Ryan C, et al. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers’ Criteria. Age Ageing 2008; 37: 96–101.PubMedCrossRef
2.
go back to reference Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767–77.PubMedCrossRef Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767–77.PubMedCrossRef
3.
go back to reference Buajordet I, Ebbesen J, Erikssen J, et al. Fatal adverse drug events: the paradox of drug treatment. J Intern Med 2001; 250: 327–41.PubMedCrossRef Buajordet I, Ebbesen J, Erikssen J, et al. Fatal adverse drug events: the paradox of drug treatment. J Intern Med 2001; 250: 327–41.PubMedCrossRef
4.
go back to reference Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5.PubMedCrossRef Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5.PubMedCrossRef
5.
go back to reference Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in elderly inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200–9.PubMedCrossRef Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in elderly inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200–9.PubMedCrossRef
6.
go back to reference Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the gerontoNet ADRriskscore. Arch Intern Med 2010; 170: 1142–8.PubMedCrossRef Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the gerontoNet ADRriskscore. Arch Intern Med 2010; 170: 1142–8.PubMedCrossRef
7.
go back to reference Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Med Sci 2006; 61: 511–5.CrossRef Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Med Sci 2006; 61: 511–5.CrossRef
8.
go back to reference Bero LA, Lipton HL, Bird JA. Characterisation of geriatric drug-related hospital readmissions. Med Care 1991; 29: 989–1003.PubMedCrossRef Bero LA, Lipton HL, Bird JA. Characterisation of geriatric drug-related hospital readmissions. Med Care 1991; 29: 989–1003.PubMedCrossRef
9.
go back to reference Scott IA, Jayathissa S. Quality of drug prescribing in older patients: is there a problem and can we improve it? Intern Med J 2010; 40: 7–18.PubMedCrossRef Scott IA, Jayathissa S. Quality of drug prescribing in older patients: is there a problem and can we improve it? Intern Med J 2010; 40: 7–18.PubMedCrossRef
10.
go back to reference The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60: 616–31.CrossRef The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60: 616–31.CrossRef
11.
go back to reference McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156: 385–7.PubMed McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156: 385–7.PubMed
12.
go back to reference Barry PJ, O’Keefe N, O’Connor KA, et al. Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the Improved Prescribing in the Elderly Tool (IPET) in acutely ill elderly hospitalised patients. J Clin Pharm Ther 2006; 31: 617–26.PubMedCrossRef Barry PJ, O’Keefe N, O’Connor KA, et al. Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the Improved Prescribing in the Elderly Tool (IPET) in acutely ill elderly hospitalised patients. J Clin Pharm Ther 2006; 31: 617–26.PubMedCrossRef
13.
go back to reference Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007; 32: 113–21.PubMedCrossRef Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007; 32: 113–21.PubMedCrossRef
14.
go back to reference O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008; 37: 138–41.PubMedCrossRef O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008; 37: 138–41.PubMedCrossRef
15.
go back to reference Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatrics Soc 2007; 55 Suppl. 2: S373–82.CrossRef Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatrics Soc 2007; 55 Suppl. 2: S373–82.CrossRef
16.
go back to reference Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Persons’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72–83.PubMed Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Persons’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72–83.PubMed
17.
go back to reference Pollock M, Bazaldua OV, Dobbie A. Appropriate prescribing of medications: an eight-step approach. Am Fam Physician 2007; 75: 231–6.PubMed Pollock M, Bazaldua OV, Dobbie A. Appropriate prescribing of medications: an eight-step approach. Am Fam Physician 2007; 75: 231–6.PubMed
18.
go back to reference Steinman MA, Hanlon JT. Managing medications in clinically complex elders: “there’s got to be a happy medium.” JAMA 2010; 304: 1592–601.PubMedCrossRef Steinman MA, Hanlon JT. Managing medications in clinically complex elders: “there’s got to be a happy medium.” JAMA 2010; 304: 1592–601.PubMedCrossRef
19.
go back to reference Scott IA, Gray LC, Martin JH, et al. Minimising inappropriate medications in older populations: a 10-step conceptual framework. Am J Med 2012; 125: 529–37.PubMedCrossRef Scott IA, Gray LC, Martin JH, et al. Minimising inappropriate medications in older populations: a 10-step conceptual framework. Am J Med 2012; 125: 529–37.PubMedCrossRef
20.
go back to reference Bond C, Matheson C, Williams S, et al. Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions. Br J Gen Pract 2000; 50: 271–5.PubMed Bond C, Matheson C, Williams S, et al. Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions. Br J Gen Pract 2000; 50: 271–5.PubMed
21.
go back to reference Budnitz DS, Lovegrove LC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365: 2002–12.PubMedCrossRef Budnitz DS, Lovegrove LC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365: 2002–12.PubMedCrossRef
22.
go back to reference Mark TL, Swait J. Using stated preference and revealed preference modeling to evaluate prescribing decisions. Health Econ 2004; 13: 563–73.PubMedCrossRef Mark TL, Swait J. Using stated preference and revealed preference modeling to evaluate prescribing decisions. Health Econ 2004; 13: 563–73.PubMedCrossRef
23.
go back to reference Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. Implications for pay for performance. JAMA 2005; 294: 716–24.PubMedCrossRef Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. Implications for pay for performance. JAMA 2005; 294: 716–24.PubMedCrossRef
Metadata
Title
Effects of a Drug Minimization Guide on Prescribing Intentions in Elderly Persons with Polypharmacy
Authors
Dr Ian A. Scott, MBBS, FRACP, MHA, MEd
Leonard C. Gray
Jennifer H. Martin
Charles A. Mitchell
Publication date
01-08-2012
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 8/2012
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/BF03262281

Other articles of this Issue 8/2012

Drugs & Aging 8/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.